Aurora Cannabis Expands Medical Cannabis Pastille Offerings in Australia
- Aurora Cannabis Inc. Has expanded its pastille offerings in Australia, introducing new products like Aurora Pastilles- 10mg THC Pomegranate Berry and Aurora Pastilles- 25mg CBD Acai Berry .
- The expansion reflects Aurora's commitment to providing a diverse range of high-quality medical cannabis products for various patient needs and preferences.
- Andre Jerome, Executive Vice President of Global Business Development at Aurora, stated that this expansion shows Aurora's understanding of market demand as patient interest increases.
- Aurora Cannabis remains the largest global medical cannabis company operating in legally permitted markets.
Insights by Ground AI
Does this summary seem wrong?
37 Articles
37 Articles
All
Left
4
Center
6
Right
2
Coverage Details
Total News Sources37
Leaning Left4Leaning Right2Center6Last UpdatedBias Distribution50% Center
Bias Distribution
- 50% of the sources are Center
50% Center
L 33%
C 50%
R 17%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage